Jump to content
 







Main menu
   


Navigation  



Main page
Contents
Current events
Random article
About Wikipedia
Contact us
Donate
 




Contribute  



Help
Learn to edit
Community portal
Recent changes
Upload file
 








Search  

































Create account

Log in
 









Create account
 Log in
 




Pages for logged out editors learn more  



Contributions
Talk
 



















Contents

   



(Top)
 


1 See also  





2 References  














Nabitan






Deutsch
Српски / srpski
Srpskohrvatski / српскохрватски
 

Edit links
 









Article
Talk
 

















Read
Edit
View history
 








Tools
   


Actions  



Read
Edit
View history
 




General  



What links here
Related changes
Upload file
Special pages
Permanent link
Page information
Cite this page
Get shortened URL
Download QR code
Wikidata item
 




Print/export  



Download as PDF
Printable version
 




In other projects  



Wikimedia Commons
 
















Appearance
   

 






From Wikipedia, the free encyclopedia
 


Nabitan
Clinical data
ATC code
  • none
Identifiers
  • 5,5-Dimethyl-8-(3-methyloctan-2-yl)-2-(prop-2-yn-1-yl)-1,3,4,5-tetrahydro-2H-[1]benzopyrano[4,3-c]pyridin-10-yl 4-(piperidin-1-yl)butanoate

CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC35H52N2O3
Molar mass548.812 g·mol−1
3D model (JSmol)
  • O=C(Oc2cc(cc1OC(C\3=C(/c12)CN(CC/3)CC#C)(C)C)C(C)C(C)CCCCC)CCCN4CCCCC4

  • InChI=1S/C35H52N2O3/c1-7-9-11-15-26(3)27(4)28-23-31(39-33(38)16-14-21-36-19-12-10-13-20-36)34-29-25-37(18-8-2)22-17-30(29)35(5,6)40-32(34)24-28/h2,23-24,26-27H,7,9-22,25H2,1,3-6H3 checkY

  • Key:MCVPMHDADNVRKF-UHFFFAOYSA-N checkY

  (verify)

Nabitan (Nabutam, Benzopyranoperidine, SP-106, Abbott 40656) is a synthetic cannabinoid analogofdronabinol (Marinol) and dimethylheptylpyran.[1] It exhibits antiemetic and analgesic effects, most likely by binding to and activating the CB1 and CB2 cannabinoid receptors, and reduced intraocular pressure in animal tests, making it potentially useful in the treatment of glaucoma.[2]

Nabitan has the advantage of being water-soluble, unlike most cannabinoid derivatives, and was researched for potential use as an analgesic or sedative,[3] although it was never developed for clinical use and is not currently used in medicine, as dronabinolornabilone were felt to be more useful. However it is sometimes used in research into the potential therapeutic applications of cannabinoids.

See also[edit]

References[edit]

  1. ^ Razdan RK. The Total Synthesis of Cannabinoids. Wiley-Interscience 1980
  • ^ Razdan RK, Howes JF (1983). "Drugs related to tetrahydrocannabinol". Medicinal Research Reviews. 3 (2): 119–46. doi:10.1002/med.2610030203. PMID 6134882. S2CID 31313909.
  • ^ Archer RA (1974). "The cannabinoids: therapeutic potentials". Annual Reports in Medicinal Chemistry. 9: 253–9. doi:10.1016/s0065-7743(08)61448-7. PMID 12307093.
  • t
  • e

  • Retrieved from "https://en.wikipedia.org/w/index.php?title=Nabitan&oldid=1216511770"

    Categories: 
    Drugs not assigned an ATC code
    Propargyl compounds
    Carboxylate esters
    Cannabinoids
    Benzopyrans
    Nitrogen heterocycles
    Oxygen heterocycles
    Heterocyclic compounds with 3 rings
    1-Piperidinyl compounds
    Cannabinoid stubs
    Hidden categories: 
    Articles with short description
    Short description is different from Wikidata
    Articles without EBI source
    Chemical pages without DrugBank identifier
    Articles without KEGG source
    Drugs with no legal status
    All stub articles
     



    This page was last edited on 31 March 2024, at 12:25 (UTC).

    Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.



    Privacy policy

    About Wikipedia

    Disclaimers

    Contact Wikipedia

    Code of Conduct

    Developers

    Statistics

    Cookie statement

    Mobile view



    Wikimedia Foundation
    Powered by MediaWiki